Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Inventory: 2009-2025

Historic Inventory for Prestige Consumer Healthcare (PBH) over the last 16 years, with Sep 2025 value amounting to $159.0 million.

  • Prestige Consumer Healthcare's Inventory rose 1.77% to $159.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $159.0 million, marking a year-over-year increase of 1.77%. This contributed to the annual value of $147.7 million for FY2025, which is 6.48% up from last year.
  • As of Q3 2025, Prestige Consumer Healthcare's Inventory stood at $159.0 million, which was up 3.83% from $153.1 million recorded in Q2 2025.
  • In the past 5 years, Prestige Consumer Healthcare's Inventory registered a high of $169.8 million during Q2 2023, and its lowest value of $105.5 million during Q2 2021.
  • Its 3-year average for Inventory is $154.6 million, with a median of $153.1 million in 2025.
  • Per our database at Business Quant, Prestige Consumer Healthcare's Inventory skyrocketed by 49.16% in 2022 and then declined by 14.44% in 2024.
  • Over the past 5 years, Prestige Consumer Healthcare's Inventory (Quarterly) stood at $106.3 million in 2021, then skyrocketed by 49.16% to $158.5 million in 2022, then dropped by 6.24% to $148.6 million in 2023, then climbed by 1.94% to $151.5 million in 2024, then grew by 1.77% to $159.0 million in 2025.
  • Its last three reported values are $159.0 million in Q3 2025, $153.1 million for Q2 2025, and $147.7 million during Q1 2025.